A rare intrauterine onset growth retardation syndrome caused by mosaic 19p13.3 microduplication: evaluation of GH/IGF-1 axis and GH therapy response

Creative Commons License

Ozer E., KARAMAN B., Gunes N., Evliyaoglu O., Tuysuz B.

TURKISH JOURNAL OF PEDIATRICS, cilt.63, sa.1, ss.174-180, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 63 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.24953/turkjped.2021.01.022
  • Dergi Adı: TURKISH JOURNAL OF PEDIATRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.174-180
  • Anahtar Kelimeler: 19p13.3 microduplication, intrauterine growth retardation, microcephaly, PIAS4, growth hormone, INTELLECTUAL DISABILITY, DYSMORPHIC FEATURES, PURE DUPLICATION, PIAS4
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background. 19p13.3 microduplication syndrome is a newly defined intrauterine onset growth retardation syndrome characterized by microcephaly, moderate intellectual disability, speech delay, and mild dysmorphic features. The PIAS4 gene located in this region plays a crucial role as a transcriptional co-regulator in various cellular pathways including STAT, p53/TP53 and growth hormone (GH) signaling and mutations in this gene are thought to be responsible for clinical features.